H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 322,570. Kentucky Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lexington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lexington storefront.
PRP Injections & Treatment Systems in Lexington, KY for clinics & physicians. Add PRP injections to your p… Compliance support & pricing — contact Hawk Medical.
CDC PLACES does not publish an arthritis rate for Lexington. Plan joint volume from your referral mix, not a made-up city figure. CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Together those PLACES numbers are why a city of 250k–500k still needs separate PRP and CTP protocols. prp injections inventory is national; utilization is J15-local.
National PRP Injections & Treatment Systems notes (how the product actually works)J15 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Lexington is unpublished at place grain or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, J15 articles mapped. We do not have a CDC PLACES uninsured rate for Lexington. Expect a mix of J15 fee-for-service, Advantage, workers’ comp, and cash-pay, and price them as separate tickets. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES has no incorporated-place row we could match for Lexington. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Kentucky.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Kentucky compliance risk.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed Kentucky clinician.
If you operate in Kentucky and another MAC state, say it on the first call. J15 will not port 1:1. We would rather split utilization than watch a sister clinic copy Lexington tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Lexington, KY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lexington is J15 geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Kentucky Part B wound biologics follow this contractor (siblings: OH). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 250k–500k, not a count of orthopedic groups.
No Lexington storefront. Joe Bradley is an active practice owner. prp injections stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.